Feb 4 (Reuters) - Aequus Pharmaceuticals Inc AQS.V :
* Announces positive results from single-dose bioavailability study of
aripiprazole transdermal patch
* Formulation is expected to be advanced into 2nd stage of proof of concept
study to be initiated during the first half of 2016
* Source text for Eikon ID:nMKWW61lNa
* Further company coverage AQS.V